Clipping of news on Brazilian Culture, Law and Citizenship
01.04.2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
1 - People with less than nine years and more than 45 can get the vaccine?
The vaccine is approved for pediatric and adult use, from nine to 45 years old. The age limits were based mainly on vaccine safety information obtained during the course of clinical trials. Children under nine years, the risk of serious complications remains to be determined; for those over 45 years of age, there is insufficient data to ensure the safety of the vaccine.
The attending physician can evaluate the risk / benefit of using the vaccine at different ages recommended in the text of the label.
2 - If I have just turned 46, I get the vaccine?
As clarifies the previous question, vaccine is approved for pediatric and adult use, from nine to 45 years old. The use of different ages recommended in the package insert text should be discussed with the doctor, who will assess the risk / benefit of the use of the vaccine.
3 - My daughter, son, nephew etc. It will still have eight when launching the vaccine, but nine years soon complete next. She (e) may be immunized (o)?
Because the vaccine is approved for pediatric and adult use, from nine to 45 years of age, should not be given to children under nine years old This is because the available clinical data are not sufficient to conclude on the risk / benefit of vaccination this age group. The use of Dengvaxia® at different ages recommended in the text of the leaflet should be discussed with the doctor, who will assess the risk / benefit of the use of the vaccine.
4 - The vaccine also immunized against Chicungunya and Zica against viruses transmitted by Aedes aegypti?
The vaccine does not protect against Chikungunya and Zika virus.
The Dengvaxia® is a vaccine used to help protect against dengue caused by serotypes 1, 2, 3 and 4 of the dengue virus. The vaccine is applied in adults, adolescents and children from nine to 45 years old who live in endemic areas (areas where dengue is always present).
5 - If I take two doses of vaccine and forget to take the last, I will be immunized? if I take just one dose, the vaccine will take effect?
The approved vaccination schedule consists of three injections were administered at intervals of six months.
The vaccine begins to take effect from the first dose. However, efficacy was demonstrated only after the application of three doses.
6 - What should the interval between doses of the vaccine?
The immunization regimen consists of three injections to be administered subcutaneously, at intervals of six months.
7 - The vaccine is contraindicated for people with some kind of allergy?
The vaccine is contraindicated for use by people who are allergic (hypersensitive) to the active substances or any other ingredient of Dengvaxia® and people who have developed an allergic reaction after previous administration of Dengvaxia®. Signs of an allergic reaction may include hives, breathing shortening and swelling of the face and tongue.
8 - I've had dengue. Can I get the vaccine?
Yes you can. The vaccine was approved for both people who never had dengue as for those who already had the disease.
9 - If I am with dengue, can I get the vaccine?
No. The vaccine does not treat the disease, it warns. With the restoration of health, vaccination may be considered after evaluation of the physician.
10 - Pregnant women may be vaccinated?
No, this is a contraindication of the vaccine. Dengvaxia® is a live attenuated vaccine and contraindicated for pregnant women. Pregnant women have not been evaluated in clinical studies.
11 - The vaccine gives fever? What are the main side effects?
It is possible that the vaccine causes fever and other adverse effects, although this does not happen with everyone. The most common adverse reactions observed in clinical trials were fever, headache, pain at the injection site, malaise and muscle pain. Other common reactions were injection site reactions such as redness, bruising, swelling and itching. Rare reactions were: induration at the injection site, flu-like illness, neck pain, joint pain, severe redness, hives, nausea, sore mouth and throat, cough, runny nose, dizziness, headache, swollen lymph nodes ( lymphadenopathy) and infection of the upper respiratory tract (nose, mouth, pharynx and larynx).
12 - Can I donate blood after taking the vaccine?
As the dengue vaccine is a live attenuated vaccine virus, it is necessary to wait a period of four weeks after vaccination to make blood donation.
13 - The day after taking the vaccine will be immunized and protected against dengue?
As the vaccination schedule consists of three doses must be administered at intervals of six months, protection against the disease will be achieved after the full course of three doses, ie one year after the first dose.
14 - Even after taking the vaccine should continue using mosquito repellent?
Yes. Vaccination is not a substitute for protection against mosquito bites. Should be taken the appropriate precautions to prevent mosquito bites, including using repellent, appropriate clothing and mosquito nets. The vaccine only protects against dengue fever caused by serotypes 1, 2, 3 and 4 of the dengue virus. The dengue mosquito is also responsible for the transmission of other viruses such as Chikungunya and Zika, for which dengue vaccine does not offer protection.
15 - Who should not use the vaccine?
Children under nine years old, pregnant or lactating, people allergic to components of the vaccine, people who have phenylketonuria and those with a weakened immune system or receiving specific medical advice.
16 - The vaccine can cause dengue hemorrhagic fever?
No. serious and dengue hemorrhagic fever.
17 - What is the composition of the vaccine?
The vaccine consists of live attenuated viruses obtained by recombinant DNA technology, combining the attenuated yellow fever virus and the four serotypes of dengue viruses.
18 - Can I take other vaccines along with the dengue vaccine?
The Dengvaxia® should not be administered with any other vaccine or injectable pharmaceutical product.
No specific study has been conducted on the concomitant administration of the vaccine against dengue and any other vaccine or pharmaceutical product.
After medical assessment, if necessary concomitantly administered vaccine or any other pharmaceutical product, must be different syringes and needles used, and the application must be made in different parts of the body.
In clinical studies, the vaccine has greatly reduced cases of dengue.
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.